- Report
- April 2025
- 141 Pages
Global
From €3587EUR$3,999USD£3,098GBP
- Report
- January 2026
- 196 Pages
Global
From €3180EUR$3,545USD£2,746GBP
€3533EUR$3,939USD£3,051GBP
- Report
- August 2025
- 185 Pages
Global
From €4036EUR$4,500USD£3,486GBP
- Report
- March 2026
- 254 Pages
Global
From €5247EUR$5,850USD£4,532GBP
- Report
- May 2025
- 120 Pages
Global
From €4261EUR$4,750USD£3,680GBP
- Report
- August 2025
- 189 Pages
Global
From €3180EUR$3,545USD£2,746GBP
€3533EUR$3,939USD£3,051GBP
- Report
- May 2025
- 120 Pages
Global
From €5337EUR$5,950USD£4,609GBP
- Report
- January 2026
- 191 Pages
Global
From €3180EUR$3,545USD£2,746GBP
€3533EUR$3,939USD£3,051GBP
- Report
- January 2026
- 193 Pages
Global
From €3180EUR$3,545USD£2,746GBP
€3533EUR$3,939USD£3,051GBP
- Report
- January 2026
- 196 Pages
Global
From €3180EUR$3,545USD£2,746GBP
€3533EUR$3,939USD£3,051GBP
- Report
- January 2026
- 195 Pages
Global
From €3180EUR$3,545USD£2,746GBP
€3533EUR$3,939USD£3,051GBP
- Report
- January 2026
- 196 Pages
Global
From €3180EUR$3,545USD£2,746GBP
€3533EUR$3,939USD£3,051GBP
- Report
- February 2026
- 250 Pages
Global
From €4027EUR$4,490USD£3,478GBP
- Report
- February 2026
- 250 Pages
Global
From €4027EUR$4,490USD£3,478GBP
- Report
- February 2026
- 250 Pages
Global
From €4027EUR$4,490USD£3,478GBP
- Report
- February 2026
- 250 Pages
Global
From €4027EUR$4,490USD£3,478GBP
- Report
- February 2026
- 250 Pages
Global
From €4027EUR$4,490USD£3,478GBP
- Report
- February 2026
- 250 Pages
Global
From €4027EUR$4,490USD£3,478GBP
- Report
- February 2026
- 250 Pages
Global
From €4027EUR$4,490USD£3,478GBP
- Report
- February 2026
- 250 Pages
Global
From €4027EUR$4,490USD£3,478GBP

The Infection Surveillance Solutions market is a subset of the Infectious Disease Testing market, focusing on the development of solutions to monitor and track the spread of infectious diseases. These solutions are designed to provide healthcare professionals with the data and insights they need to identify and respond to potential outbreaks. Solutions may include software, hardware, and services that enable the collection, analysis, and sharing of data related to infectious diseases.
The Infection Surveillance Solutions market is driven by the need to improve public health outcomes and reduce the economic impact of infectious diseases. Governments, healthcare providers, and other stakeholders are increasingly investing in solutions to better understand and respond to the spread of infectious diseases.
Companies in the Infection Surveillance Solutions market include IBM, Epic Systems, Cerner Corporation, Allscripts, and Athenahealth. Show Less Read more